Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$373.39M
Total Bought:
$55.64M
Total Sold:
$52.06M
Net Transaction:
+$3.58M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)29,82131,202+1,381$35.77M$36.10M9.67%+$335.0K
Merck & Co., Inc.(MRK)189,357168,987-20,370$24.33M$24.56M6.58%+$223.1K
Johnson & Johnson(JNJ)85,42591,387+5,962$21.70M$24.19M6.48%+$2.50M
AbbVie Inc.(ABBV)64,32591,294+26,969$16.19M$23.88M6.40%+$7.69M
Thermo Fisher Scientific Inc.(TMO)27,85934,410+6,551$13.97M$23.23M6.22%+$9.26M
Biogen Inc.(BIIB)62,78170,955+8,174$13.56M$16.03M4.29%+$2.46M
Vertex Pharmaceuticals Incorporated(VRTX)19,13128,157+9,026$9.50M$14.72M3.94%+$5.22M
Revolution Medicines, Inc.(RVMD)73,07766,113-6,964$13.69M$13.57M3.63%-$115.5K
BeOne Medicines AGADS(ONC)35,18035,679+499$10.03M$13.06M3.50%+$3.03M
CVS Health Corporation(CVS)146,102139,311-6,791$15.11M$11.94M3.20%-$3.18M
Cencora Inc31,12636,107+4,981$8.81M$10.84M2.90%+$2.03M
BridgeBio Pharma, Inc.(BBIO)124,707163,697+38,990$9.29M$10.77M2.88%+$1.48M
Intuitive Surgical, Inc.(ISRG)24,65625,648+992$9.81M$10.43M2.79%+$624.0K
Insmed Incorporated(INSM)58,37887,469+29,091$6.22M$9.98M2.67%+$3.76M
Edwards Lifesciences Corp103,230109,647+6,417$9.34M$9.46M2.53%+$126.5K
Stryker Corporation(SYK)30,28334,296+4,013$9.53M$9.44M2.53%-$89.5K
Incyte Corporation(INCY)56,95377,377+20,424$6.46M$9.39M2.51%+$2.93M
Krystal Biotech, Inc.(KRYS)24,01928,074+4,055$8.93M$9.34M2.50%+$409.1K
DexCom, Inc.(DXCM)71,84689,251+17,405$4.84M$7.70M2.06%+$2.86M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
248,848303,824+54,976$8.43M$7.39M1.98%-$1.04M
iRhythm Holdings, Inc.(IRTC)54,10254,1020$6.44M$6.15M1.65%-$286.2K
Gilead Sciences, Inc.(GILD)46,14240,461-5,681$5.83M$6.03M1.62%+$201.1K
Mirum Pharmaceuticals, Inc.(MIRM)100,80770,071-30,736$11.80M$5.99M1.60%-$5.81M
Cardinal Health, Inc.(CAH)23,63026,735+3,105$5.61M$5.95M1.59%+$335.0K
Boston Scientific Corporation(BSX)146,381130,622-15,759$6.25M$5.70M1.53%-$545.9K
Alkermes plcSHS(ALKS)213,329136,225-77,104$11.18M$5.52M1.48%-$5.66M
Neurocrine Biosciences, Inc.(NBIX)72,89838,611-34,287$12.29M$5.48M1.47%-$6.81M
Tango Therapeutics, Inc.(TNGX)198,557184,394-14,163$6.21M$4.60M1.23%-$1.61M
ABIVAX Société AnonymeADS(ABVX)58,17046,452-11,718$7.75M$4.60M1.23%-$3.15M
Spyre Therapeutics, Inc.(SYRE)57,03044,243-12,787$5.06M$3.94M1.05%-$1.12M
Oruka Therapeutics, Inc.(ORKA)54,88643,180-11,706$5.22M$3.60M0.96%-$1.63M
IDEAYA Biosciences, Inc.(IDYA)94,47893,550-928$3.52M$3.59M0.96%+$73.0K
Summit Therapeutics Inc.(SMMT)0184,687+184,687$0$3.12M0.84%+$3.12M
COMPASS Pathways plcADS(CMPS)0243,506+243,506$0$3.03M0.81%+$3.03M
Disc Medicine, Inc.(IRON)43,68243,6820$3.19M$2.86M0.77%-$335.5K
Celcuity Inc.(CELC)33,31329,893-3,420$3.49M$2.38M0.64%-$1.11M
Palvella Therapeutics, Inc.(PVLA)014,924+14,924$0$2.06M0.55%+$2.06M
Pyxis Oncology Inc966,459663,772-302,687$2.91M$1.55M0.41%-$1.36M
Veradermics, Incorporated(MANE)010,106+10,106$0$1.23M0.33%+$1.23M
Bicara Therapeutics Inc145,6570-145,657$4.32M$0—-$4.32M
Compass Therapeutics, Inc.(CMPX)1,048,5930-1,048,593$2.30M$0—-$2.30M
Ionis Pharmaceuticals, Inc.(IONS)137,1310-137,131$10.87M$0—-$10.87M
Jade Biosciences88,5560-88,556$1.97M$0—-$1.97M
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q3 2026 | TickerTrail